Xilio Therapeutics, Inc.XLONASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+71.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+71.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
15x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$15.99M-
2024$0.00-
2023$0.00-
2022$0.00-100.0%
2021$1.50M+40.8%
2020$1.06M+343.8%
2019$240000.00-